National Science Foundation

The National Science Foundation (NSF), established in 1950 and located in Alexandria, Virginia, is an independent federal agency dedicated to advancing fundamental research and education across all scientific and engineering disciplines. With an annual budget of approximately $7.8 billion, the NSF operates America's Seed Fund, which allocates nearly $200 million each year to support startups and small businesses through the Small Business Innovation Research (SBIR) program. This initiative provides non-dilutive funding of up to $1.5 million to assist in research and development efforts, thereby facilitating the transformation of scientific discoveries into commercially viable products and services. By helping to de-risk technology, the NSF plays a crucial role in fostering innovation and addressing societal challenges through scientific advancements.

James Donlon

Program Director

Sean L. Jones

Assistant Director for Mathematical and Physical Sciences

Sethuraman Panchanathan

Director

Ben Schrag Ph.D

Program Director and Policy Liaison, SBIR / STTR

Past deals in Montana

Immersive Reality Group, founded in 2004 and based in Bozeman, Montana, specializes in using artificial intelligence and virtual reality technology to deliver personalized healthcare solutions focused on mental health. The company operates a platform designed for stress and anxiety management, which integrates predictive analytics for health monitoring in a home setting. Through its innovative virtual reality experiences, Immersive Reality Group aims to provide users with real-time relief from stress and anxiety symptoms while also offering tools to develop effective coping strategies.

FYR Diagnostics

Grant in 2020
FYR Diagnostics, founded in 2016 and based in Missoula, Montana, focuses on developing biomarker detection technology aimed at addressing chronic diseases in both human healthcare and agriculture. The company aims to tackle significant clinical challenges by commercializing innovative technologies that enhance the prediction, diagnosis, and management of diseases. This approach targets disorders that currently suffer from inadequate treatment and diagnostic options, thereby offering potential solutions for healthcare professionals and agricultural sectors facing substantial unmet needs.

Prime Labs

Grant in 2020
Developer of a cloud-based SaaS platform designed to provide data relating to medical drug discovery. The company's software specializes in providing mass spectrometry data processing, analysis, reporting, and visualization for every instrument, molecule, algorithm, and workflow, allowing scientists to research and develop drugs and providing them with tools for spectrometry.

ChameleonCloud

Grant in 2020
Cloud services have become ubiquitous to all major 21st century economic activities. However, cloud services and technologies can be significantly more powerful than they are now. A persistent barrier to further advancement has been the lack of a large-scale and open cloud research platforms. With funding from the National Science Foundation (NSF), the Chameleon project will provide such a large-scale platform to the open research community allowing them explore transformative concepts in deeply programmable cloud services, design, and core technologies. Chameleon will allow users to explore problems ranging from the creation of Software as a Service to kernel support for virtualization. This broad range of supported research includes many other areas such as developing Platforms as a Service, creating new and optimizing existing Infrastructure as a Service components, investigating software-defined networking, and optimizing virtualization technologies. The Chameleon testbed, will be deployed at the University of Chicago and the Texas Advanced Computing Center and will consist of 650 multi-core cloud nodes, 5PB of total disk space, and leverage 100 Gbps connection between the sites. While a large part of the testbed will consist of homogenous hardware to support large-scale experiments, a portion of it will support heterogeneous units allowing experimentation with high-memory, large-disk, low-power, GPU, and co-processor units. The project will also leverage existing FutureGrid hardware at the University of Chicago and the Texas Advanced Computing Center in its first year to provide a transition period for the existing FutureGrid community of experimental users. To support the broad range of experiments experiments described above, the project will support a graduated configuration system allowing full user configurability of the software stack, from provisioning of bare metal and network interconnects to delivery of fully functioning cloud environments. A special feature of Chameleon is that it provides for an exceptionally close integration of clouds and networks, which substantially enhances the capabilities of both. In addition, to facilitate experiments, Chameleon will support a set of services designed to meet researchers needs, including support for experimental management, reproducibility, and repositories of trace and workload data of production cloud workloads. The project is led by the Computation Institute at the University of Chicago and partners from the Texas Advanced Computing Center at the University of Texas at Austin, the International Center for Advanced Internet Research at Northwestern University, the Ohio State University, and University of Texas at San Antonio, comprising a highly qualified and experienced team. The team includes members from the NSF supported FutureGrid project and from the GENI community, both forerunners of the NSFCloud solicitation under which this project is funded. Chameleon will also form a set of partnerships with commercial and academic clouds, such as Rackspace, CERN and Open Science Data Cloud (OSDC), and will partner with other testbeds, notably GENI and INRIA's Grid'5000 testbed.

Prime Labs

Grant in 2019
Developer of a cloud-based SaaS platform designed to provide data relating to medical drug discovery. The company's software specializes in providing mass spectrometry data processing, analysis, reporting, and visualization for every instrument, molecule, algorithm, and workflow, allowing scientists to research and develop drugs and providing them with tools for spectrometry.

Blocky

Grant in 2019
Developer of data lineage software designed to verify the integrity of internal data. The company's software allows users to sign data files on a blockchain and then verify those signatures, each signature produces a certificate, enabling clients and their partners to verify both the integrity of the signed data file and the signature's timestamp.

Revibro Optics

Grant in 2018
Revibro Optics, founded in 2015 and based in Bozeman, Montana, specializes in developing a variable focus optic system designed to control the focus of light. The company's innovative system features variable focus mirrors that adjust curvature through a reflective membrane positioned over concentric electrode rings. This technology allows clients to effectively tune out spherical aberration in their optical systems, enhancing performance and precision in various applications.

Prime Labs

Grant in 2018
Developer of a cloud-based SaaS platform designed to provide data relating to medical drug discovery. The company's software specializes in providing mass spectrometry data processing, analysis, reporting, and visualization for every instrument, molecule, algorithm, and workflow, allowing scientists to research and develop drugs and providing them with tools for spectrometry.

Revibro Optics

Grant in 2017
Revibro Optics, founded in 2015 and based in Bozeman, Montana, specializes in developing a variable focus optic system designed to control the focus of light. The company's innovative system features variable focus mirrors that adjust curvature through a reflective membrane positioned over concentric electrode rings. This technology allows clients to effectively tune out spherical aberration in their optical systems, enhancing performance and precision in various applications.

Nature's Fynd

Grant in 2014
Nature's Fynd develops a protein production platform from extremophile organisms for consumer and industrial applications. The company was formerly known as Sustainable Bioproducts, Inc. Nature's Fynd was incorporated in 2016 and is headquartered in Chicago, Illinois with an additional office in Bozeman, Montana.
Nanovalent Pharmaceuticals is a pharmaceutical company focused on developing innovative therapeutic options that leverage targeted, nanoparticle-based antibody-drug conjugate technology. The company's platform utilizes a hybrid polymerized liposomal nanoparticle, which is specifically targeted with human antibodies and loaded with therapeutic anticancer agents. This technology aims to enhance the effectiveness and delivery of treatments, allowing healthcare professionals to address cancer more efficiently and cost-effectively. Supported by an experienced management team with a successful track record, Nanovalent Pharmaceuticals combines strong clinical expertise with operational capabilities to advance its therapeutic solutions.

S2 Corporation

Grant in 2013
At S2 Corporation, they are advancing extreme wideband sensors, expanding the possibilities and capabilities of radio frequency and data signal processing in a dynamic environment. At S2 corporation, passionate and energetic innovation is at the heart of what they do. It is this "thinking outside of the box" mentality that has been fundamental in the development and advancement of their spatial spectral holographic processing capabilities. Their core system, known as the extreme bandwidth analyzer and correlator (ebac) can be configured to support many applications including (but not limited to): - Electronic warfare & signal intelligence - Analog signal processing and data mining - Continuous/persistent rf spectral monitoring - Geo-location of transmitters - Time difference of arrival (tdoa) - Direction finding (df) - Adaptive and covert rf communications - True-time delay - Arbitrary waveform generation - Cueing & warning receiver The system is currently configured to process radio frequencies between 0.5 - 20 ghz, but can be easily modified to cover all frequencies up to 40 ghz, or even 110 ghz instantaneously! This is spectrum analysis for the future, available today.

Nature's Fynd

Grant in 2012
Nature's Fynd develops a protein production platform from extremophile organisms for consumer and industrial applications. The company was formerly known as Sustainable Bioproducts, Inc. Nature's Fynd was incorporated in 2016 and is headquartered in Chicago, Illinois with an additional office in Bozeman, Montana.
Metabolic Technologies LLC, founded in 1990 and based in Missoula, Montana, specializes in producing health and nutritional products. The company is known for its innovative use of clinically proven ingredients, including the beta-hydroxy beta-methylbutyrate (HMB) nutrient compound, which is a key component in its sports nutrition offerings. These products are designed to help athletes and other consumers prevent muscle loss, enhance strength, and improve recovery while promoting better body composition. Additionally, Metabolic Technologies licenses a range of ingredients that can be incorporated into various supplement products, making its health ingredients widely available across the market. As of June 2020, it operates as a subsidiary of TSI Health Sciences, Inc.

S2 Corporation

Grant in 2012
At S2 Corporation, they are advancing extreme wideband sensors, expanding the possibilities and capabilities of radio frequency and data signal processing in a dynamic environment. At S2 corporation, passionate and energetic innovation is at the heart of what they do. It is this "thinking outside of the box" mentality that has been fundamental in the development and advancement of their spatial spectral holographic processing capabilities. Their core system, known as the extreme bandwidth analyzer and correlator (ebac) can be configured to support many applications including (but not limited to): - Electronic warfare & signal intelligence - Analog signal processing and data mining - Continuous/persistent rf spectral monitoring - Geo-location of transmitters - Time difference of arrival (tdoa) - Direction finding (df) - Adaptive and covert rf communications - True-time delay - Arbitrary waveform generation - Cueing & warning receiver The system is currently configured to process radio frequencies between 0.5 - 20 ghz, but can be easily modified to cover all frequencies up to 40 ghz, or even 110 ghz instantaneously! This is spectrum analysis for the future, available today.

S2 Corporation

Grant in 2012
At S2 Corporation, they are advancing extreme wideband sensors, expanding the possibilities and capabilities of radio frequency and data signal processing in a dynamic environment. At S2 corporation, passionate and energetic innovation is at the heart of what they do. It is this "thinking outside of the box" mentality that has been fundamental in the development and advancement of their spatial spectral holographic processing capabilities. Their core system, known as the extreme bandwidth analyzer and correlator (ebac) can be configured to support many applications including (but not limited to): - Electronic warfare & signal intelligence - Analog signal processing and data mining - Continuous/persistent rf spectral monitoring - Geo-location of transmitters - Time difference of arrival (tdoa) - Direction finding (df) - Adaptive and covert rf communications - True-time delay - Arbitrary waveform generation - Cueing & warning receiver The system is currently configured to process radio frequencies between 0.5 - 20 ghz, but can be easily modified to cover all frequencies up to 40 ghz, or even 110 ghz instantaneously! This is spectrum analysis for the future, available today.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.